CVC (CVC NA) is said to explore divestments for Recordati (REC IM) after takeover, Bloomberg reports; could consider a sale of Recordati’s rare-diseases arm as one of the alternatives

Newsquawk StaffPublished
Newsquawk headlinesUTC

Every headline is on the live feed 20 minutes before this site.

Saudi Arabia and Ukraine sign defence procurement memorandum

White House expects Iranian response to 15-point proposal today, CBS reports, citing sources; President Trump and top White House officials have been told that Iran's counter-proposal would likely arrive Friday via interlocutors

CVC (CVC NA) is said to explore divestments for Recordati (REC IM) after takeover, Bloomberg reports; could consider a sale of Recordati’s rare-diseases arm as one of the alternatives

Newsquawk European Market Wrap - 27th March 2026

Fed's Barkin (2027 Voter) says even before oil shock, progress on inflation was at risk of stalling, rates should be on hold; war and fast changes due to AI have clouded the economic outlook

On the Newsquawk feed at , 20 minutes before this page.

Use the PlatformFree. No signup, no card.

Context

CVC's exploration of divestments for Recordati following their takeover indicates a strategic shift that could enhance liquidity or refocus on core operations. The potential sale of Recordati’s rare-diseases division points to a prioritization of profitability and may influence investor sentiment regarding the overall value and direction of Recordati's portfolio. Watch for reactions from the market, especially within the healthcare sector, as peers may follow suit in evaluating their own non-core assets.

Related headlines

The feed had this first.

Use the Platform